Showing results (11-20 of 343) with videos related to

Sort By:
Pageof 35
International Journal of Radiation Oncology, Biology, Physics|September 25, 2020
Oligometastasis: Past, Present, FutureStanley I Gutiontov, Sean P Pitroda, Ralph R Weichselbaum
Trends in Cancer|November 6, 2021
Radiotherapy and immunotherapy: open questions and future strategiesKelli B Pointer, Sean P Pitroda, Ralph R Weichselbaum
Nature Genetics|November 28, 2022
Tumor aneuploidy predicts survival following immunotherapy across multiple cancersLiam F Spurr, Ralph R Weichselbaum, Sean P Pitroda
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2025
Facts and hopes in radioimmunotherapy of oligometastatic diseaseDaniel Huang, Connor Lynch, Sean P Pitroda, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 28, 2023
Oligometastases: Characterizing the Role of Epigenetic Regulation of Epithelial-Mesenchymal TransitionRohan R Katipally, Sean P Pitroda, Ralph R Weichselbaum, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2025
Amphiregulin as a Mediator of Radiation-Induced Systemic Effects in Metastatic Cancer: Balancing Local Control with Distant ProgressionAndrás Piffkó, Sean P Pitroda, Hua Laura Liang, et al.
Nature Genetics|June 30, 2025
Tumor aneuploidy as a prognostic and predictive biomarker in immune checkpoint blockadeDaniel Huang, Liam F Spurr, Ralph R Weichselbaum, et al.
Cancer Research|January 16, 2021
(Oligo)metastasis as a Spectrum of DiseaseStanley I Gutiontov, Sean P Pitroda, Phuoc T Tran, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2024
Sharing the Burden: The Case for Definitive Local Therapy in Place of Immune Checkpoint Blockade for Patients With a Low-Volume Burden of Metastatic DiseaseConnor Lynch, Muzamil Arshad, Rohan R Katipally, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 26, 2017
Low Recombination Proficiency Score (RPS) Predicts Heightened Sensitivity to DNA-Damaging Chemotherapy in Breast CancerSean P Pitroda, Riyue Bao, Jorge Andrade, et al.
Pageof 35